Clinical Trial Update: Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of ticagrelor and clopidogrel on platelet aggregation in patients with clopidogrel resistance and coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clopidogrel Resistance
• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Platelet Reactivity | Phase 4 | Status: UNKNOWN